ETIOLOGY
- AMI
- Sepsis
- Myocarditis
- Myocardial contusion
- Valvular disease
- Cardiomyopathy
- Left atrial myxoma
- Drug toxicity:
- β-blocker
- Calcium channel blocker
- Adriamycin
DIAGNOSIS
SIGNS AND SYMPTOMS
- ABCs and vital signs:
- Patent airway (early)
- Labored breathing and tachypnea (early); respiratory failure (late)
- Diffuse crackles or wheezing
- Hypoxia
- Hypotension:
- Systolic BP <90 mm Hg
- Decline by at least 30 mm Hg below baseline level
- Tachycardia
- Weak pulses
- General:
- Cyanosis
- Pallor
- Diaphoresis
- Dulled sensorium
- Decrease in body temperature
- Urine flow of <20 mL/hr
- Neck:
- Jugular venous distention
- Cardiac:
- Ischemic chest pain
- Systolic apical blowing murmur
- Gallop rhythm:
- S3 reflects severe myocardial dysfunction.
- S4 is present in 80% patients in sinus rhythm with AMI.
- Systolic click:
- Suggests rupture of the chordae tendineae
- Abdominal:
- Epigastric pain
- Nausea and vomiting
- Neurologic:
History
- Obtain history from patient, family, or EMS for clues to possible etiology
- Medications history
Physical-Exam
- Perform rapid survey and stabilize ABCs
- Distended neck veins and cool extremities distinguish cardiogenic shock from distributive and hypovolemic shock
- Careful heart and lung exam
ESSENTIAL WORKUP
Ancillary studies further define the type and degree of cardiac injury and determine the indications for emergent catheterization or surgical intervention.
DIAGNOSIS TESTS & NTERPRETATION
ECG:
- Normal ECG does not rule out AMI.
- Findings of AMI (ST-elevations in 2 or more contiguous leads)
- May occur in non–ST-elevation acute coronary syndrome
- Dysrhythmias
- LV hypertrophy
Lab
- B-type natriuretic peptide (BNP):
- Diagnostic and prognostic value
- Creatine kinase (CK), CK-MB, troponin
- Electrolytes and renal function:
- Acute renal failure is a strong predictor of mortality.
- CBC:
- Identify anemia or elevated WBC.
- Drug levels (e.g., digoxin)
Imaging
- CXR:
- Pulmonary congestion
- Pleural effusion
- Cardiomegaly
- Pneumonia
- Pneumothorax
- Pericardial effusion
- Emergent echocardiography:
- Transthoracic echocardiography (TTE) with color Doppler
- LV contractility looking for hypokinesis, akinesis, or dyskinesis
- Acute mitral regurgitation or septal defects
- RV dilatation, tricuspid insufficiency, high pulmonary artery and RV pressures suggest pulmonary embolism
- RV hypokinesis or akinesis, RV dilatation, normal pulmonary pressures suggest RV infarction
- Pericardial effusion, right atrium or RV diastolic collapse suggest cardiac tamponade
DIFFERENTIAL DIAGNOSIS
- Obstructive shock:
- Tension pneumothorax
- Cardiac tamponade
- Pulmonary embolism
- Spontaneous esophageal rupture
- Air embolus
- Distributive shock:
- Sepsis
- Anaphylaxis
- Addisonian crisis
- Neurogenic shock
- Hypovolemic shock:
- Hemorrhage
- GI losses
- Dehydration
- Burns
TREATMENT
PRE HOSPITAL
- ABCs, IV access, O
2
, monitor
- Consider fluid bolus if no crackles
- Aspirin
- Nitroglycerin or morphine sulfate for chest pain in absence of hypotension
- Transport AMI patients to facility with 24-hr cardiac revascularization capability
INITIAL STABILIZATION/THERAPY
- ABCs
- 2 large-bore peripheral IV lines
- Cardiac monitor
- Endotracheal intubation for airway compromise:
- Consider etomidate for induction (minimal effect on BP)
- Fluid challenge (100–250 mL normal saline) in absence of pulmonary congestion
- Foley catheter to monitor urine output
ED TREATMENT/PROCEDURES
- AMI:
- Aspirin
- Heparin
- Thrombolysis if percutaneous coronary intervention or bypass surgery not available
- GP IIb/IIIa inhibitors prior to percutaneous coronary intervention
- Hypotension:
- Norepinephrine is 1st-line vasopressor
- Consider dopamine in absence of NE
- Normotensive patient:
- Dobutamine may be used with NE or dopamine; combine with nitroprusside in acute mitral regurgitation
- Milrinone may be considered in conjunction with dobutamine or dopamine
- Pulmonary edema:
- Nitroglycerin drip or furosemide in the normotensive patient
- Prompt cardiology consultation is crucial for the initiation of the following therapies:
- IABP independently improves survival in experienced centers
- Early revascularization is the single most important life-saving measure
MEDICATION
- Dobutamine: 3–5 μg/kg/min, titrate to 20–50 μg/kg/min as needed IV
- Dopamine: 3–5 μg/kg/min, titrate to 20–50 μg/kg/min as needed IV
- Furosemide: 40–80 mg/d (peds: 1 mg/kg IV or IM, not to exceed 6 mg/kg) IV or IM
- Milrinone: 50 μg/kg loading dose, 0.375–0.75 μg/kg/min continuous infusion IV
- Nitroglycerin: 10–20 μg/min (peds: 0.1–1 μg/kg/min) IV, USE NON-PVC tubing
- Nitroprusside: 0.3 μg/kg/min, titrate to a max. of 10 μg/kg/min IV
- Norepinephrine: 2 μg/min, titrate up as needed IV
FOLLOW-UP
DISPOSITION
Admission Criteria
All patients in cardiogenic shock require admission to a critical care unit.
PEARLS AND PITFALLS
- Cardiogenic shock is the leading cause of death in inpatient AMI.
- Early recognition of preshock states is essential.
- Early revascularization offers better outcomes.
ADDITIONAL READING
- De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock.
N Engl J Med.
2010;362:779–789.
- Peacock WF, Weber JE. Cardiogenic shock. In: Tinitinalli JE, Stapczynski JS, eds.
Emergency Medicine: A Comprehensive Study Guide
. New York, NY: McGraw-Hill; 2010.
- Reynolds HR, Hochman JS. Cardiogenic shock: Current concepts and improving outcomes.
Circulation.
2008;117:686–697.
- Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock.
Crit Care Med.
2008;36:S66–S74.
See Also (Topic, Algorithm, Electronic Media Element)
Shock; MI
CODES
ICD9
785.51 Cardiogenic shock
ICD10
R57.0 Cardiogenic shock
CARDIOMYOPATHY
David T. Chiu
•
Edward Ullman